The Nasdaq Stock Market has approved MedQuist’s application for listing on its Global Market. The company has been trading on the pink sheets since 2004.
The Mount Laurel, N.J.-based company said its stock will begin trading on the Global Market under the ticker symbol MEDQ.
“We are pleased to announce the company’s listing on the Nasdaq Global Market. We believe that Nasdaq will provide our investors with a more transparent electronic market to aid their trading efficiency and liquidity needs,” said Mark Ivie, MedQuist’s interim president and CEO.
In December 2007, MedQuist cut 10 percent of its workforce in an effort to reduce operating expenses and realign its expenditures, allowing the company to regain cash flow.